TowerBrook Delta (“Delta” or “the fund”), the SFDR Article 9 Impact Fund of transatlantic investment firm TowerBrook Capital Partners (“TowerBrook”), based in London and New York, is pleased to announce the fund’s fifth platform investment –... Read more
TowerBrook Capital Partners L.P. (“TowerBrook”) today announced a majority equity investment in Washington D.C.-based Berkeley Research Group (“BRG”), an industry-leading expert services and consulting firm.
Founded in 2010, BRG is a global... Read more
We have been made aware of a cryptocurrency platform that falsely claims to be associated with TowerBrook Capital Partners. Please be advised that TowerBrook has no involvement with any cryptocurrency trading operations. The platform is likely carrying out a... Read more
TowerBrook has received a score of 100 on the Human Rights Campaign Foundation’s (HRCF) 2025 Corporate Equality Index, the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.... Read more
R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed... Read more
TowerBrook Capital Partners L.P. (“TowerBrook), the New York and London-based international investment firm, announced the exit of its minority investment in Battea-Class Action Services (“Battea”), a provider of securities claims management services,... Read more
Stockholders to Receive $14.30 Per Share in Cash
MURRAY, Utah, August 1, 2024 -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of... Read more